Gastroenterology research encompasses a wide range of topics related to the digestive system, including the structure and function of the digestive system, digestive diseases, and treatments. Research in this field has helped to improve the diagnosis and treatment of gastrointestinal disorders and has provided insight into the molecular mechanisms that drive the development and progression of these disorders. Recent advances in molecular biology, imaging, and genetics have enabled researchers to gain a better understanding of the digestive system and its disorders. For instance, researchers have identified genetic variations associated with several gastrointestinal diseases, including Crohn’s disease, ulcerative colitis, and irritable bowel syndrome. These discoveries have led to the development of improved diagnostic tests, treatments, and prevention strategies.
In addition to studies focused on the diagnosis and treatment of digestive diseases, gastroenterology researchers are also studying the microbiome, the collection of microbes that live in the gut. Recent studies have shown that changes in the microbiome can contribute to the development of certain diseases, including inflammatory bowel disease and colon cancer. Researchers are also exploring how medications, such as antibiotics, can affect the microbiome and contribute to the development of certain diseases.
KlinEra’s unique CRC model offers regional CRCs in the same city for each site. The utilization of these resources allows proactive study planning, start-up and patient recruitment which needs proper assessment and time for conducting oncology trial. Regional CRCs supports theGastroenterology study team from the site in attaining enrolment targets and timelines.
The team here in KlinEra boasts of following specialized standard processes and services needed to execute oncology trial.